Author

GALE S HARDING

Observed name: Gale Harding

Institution: Thermo Fisher Scientific (United States)

Observed institution: Thermo Fisher Scientific (United States)

OpenAlex ID: A5045803608

Asthma Impairment and Risk Questionnaire predicts short- and long-term exacerbation occurrence across asthma severities

2026 · William A. McCann, Bradley E. Chipps, et al. · Annals of Allergy Asthma & Immunology · 3

The Pediatric Asthma Impairment and Risk Questionnaire Identifies Disparities in Morbidity Between Hispanic/Latino and Non-Hispanic White Children Better Than Other Evaluations Used in Clinical Practice

2026 · Miguel Lanz, Acklema Mohammad, et al. · Journal of Allergy and Clinical Immunology

Implementation of Airq® in Diverse Practice Settings: Changes in Control Score From Baseline to Follow-up

2023 · DAVID A BEUTHER, JONATHAN TOBIN, et al. · CHEST Journal

Effects of Implementing the Asthma Impairment and Risk Questionnaire (airq) and an Associated Guideline-based Assessment Tool on Clinical Decision-making in Primary Care

2022 · BARBARA P YAWN, JONATHAN N. TOBIN, et al. · CHEST Journal

Works count: 4

Citation count: 3

H-index: 1

I10-index: